Prospects for tumor immunotherapy in man, with emphasis on its use as an adjunct to surgery for primary operable cancer.
D000818:Animals; D000917:Antibody Formation; D000951:Antigens, Neoplasm; D001500:BCG Vaccine; D001859:Bone Neoplasms / Q000628:therapy; D001943:Breast Neoplasms / Q000628:therapy; D002455:Cell Division; D005260:Female; D006168:Guinea Pigs; D006801:Humans; D007112:Immunity, Maternally-Acquired; D007165:Immunosuppression Therapy; D007167:Immunotherapy; D008297:Male; D051379:Mice; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000276:immunology / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D012516:Osteosarcoma / Q000628:therapy; D051381:Rats; D012513:Sarcoma, Experimental / Q000276:immunology; D013274:Stomach Neoplasms / Q000628:therapy; D014165:Transfer Factor; D014184:Transplantation, Homologous
D000951:Antigens, Neoplasm; D001500:BCG Vaccine; D014165:Transfer Factor